Page last updated: 2024-10-27

gabapentin and Agnosia

gabapentin has been researched along with Agnosia in 1 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Agnosia: Loss of the ability to comprehend the meaning or recognize the importance of various forms of stimulation that cannot be attributed to impairment of a primary sensory modality. Tactile agnosia is characterized by an inability to perceive the shape and nature of an object by touch alone, despite unimpaired sensation to light touch, position, and other primary sensory modalities.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gedda, C1
Nygren, J1
Garpenbeck, A1
Hoffström, L1
Thorell, A1
Soop, M1

Other Studies

1 other study available for gabapentin and Agnosia

ArticleYear
Multimodal Analgesia Bundle and Postoperative Opioid Use Among Patients Undergoing Colorectal Surgery.
    JAMA network open, 2023, 09-05, Volume: 6, Issue:9

    Topics: Agnosia; Analgesia; Analgesics, Opioid; Clonidine; Cohort Studies; Colorectal Surgery; Female; Gabap

2023